Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Continuous glucose monitoring (CGM) has provided new measures of glycemic control that link to diabetes complications. This study investigated the association between the time in range (TIR) assessed by CGM and diabetic retinopathy (DR). RESEARCH DESIGN AND METHODS: A total of 3,262 patients with type 2 diabetes were recruited. TIR was defined as the percentage of time spent within the glucose range of 3.9–10.0 mmol/L during a 24-h period. Measures of glycemic variability (GV) were assessed as well. DR was determined by using fundus photography and graded as 1) non-DR; 2) mild nonproliferative DR (NPDR); 3) moderate NPDR; or 4) vision-threatening DR (VTDR). RESULTS: The overall prevalence of DR was 23.9% (mild NPDR 10.9%, moderate NPDR 6.1%, VTDR 6.9%). Patients with more advanced DR had significantly less TIR and higher measures of GV (all P for trend <0.01). The prevalence of DR on the basis of severity decreased with ascending TIR quartiles (all P for trend <0.001), and the severity of DR was inversely correlated with TIR quartiles (r = −0.147; P < 0.001). Multinomial logistic regression revealed significant associations between TIR and all stages of DR (mild NPDR, P = 0.018; moderate NPDR, P = 0.014; VTDR, P = 0.019) after controlling for age, sex, BMI, diabetes duration, blood pressure, lipid profile, and HbA1c. Further adjustment of GV metrics partially attenuated these associations, although the link between TIR and the presence of any DR remained significant. CONCLUSIONS: TIR assessed by CGM is associated with DR in type 2 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Time in range is associated with the risk of microvascular complications and can be used for assessment of glycemic management (57).”
In the citing paper
“These results align with existing literature that emphasizes the clinical benefits of higher TIR, including reduced complications and improved overall health outcomes for individuals with diabetes19,22–24.”
From Impact of digital health interventions on glycemic control and weight management. (2025) · cites this paper as [22]
In the citing paper
“Most recently, the beneficial effects of new medications, such as sodium glucose cotransporter-2 (SGLT-2) agents have helped individuals with type 1 diabetes increase TIR (49-51).”
From Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range (2019) · cites this paper as [49]
In the citing paper
“TIR has been found to be strongly associated with the development or progression of diabetic retinopathy and microalbuminuria in type 1 and type 2 DM.16 17”
From Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease (2020) · cites this paper as [17]
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Global prevalence and major risk factors of diabetic retinopathy
Yau, J. W. Y., Rogers, S. L., Kawasaki, R., Lamoureux, E. L., Kowalski, J. W., Bek, T., Chen, S.-J., Dekker, J. M., Fletcher, A., Grauslund, J., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1909 · Cited by 4,985
Wilkinson, C. P., Ferris, F. L., Klein, R. E., Lee, P. P., Agardh, C. D., Davis, M., Dills, D., Kampik, A., Pararajasegaram, R., & Verdaguer, J. T. (2003) · Ophthalmology · doi:10.1016/s0161-6420(03)00475-5 · Cited by 3,743
Monnier, L., Mas, E., Ginet, C., Michel, F., Villon, L., Cristol, J.-P., & Colette, C. (2006) · JAMA · doi:10.1001/jama.295.14.1681 · Cited by 2,444
International consensus on use of continuous glucose monitoring
Danne, T., Nimri, R., Battelino, T., Bergenstal, R. M., Close, K. L., DeVries, J. H., Garg, S., Heinemann, L., Hirsch, I., Amiel, S. A., et al. (2017) · Diabetes Care · doi:10.2337/dc17-1600 · Cited by 2,069 · cited 2×
“However, HbA1c is unreliable in patients with anemia, hemoglobinopathies, or iron deficiency, and in patients who are pregnant (7).”
BackgroundSelf-citationContinuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
Ceriello, A., Esposito, K., Piconi, L., Ihnat, M. A., Thorpe, J. E., Testa, R., Boemi, M., & Giugliano, D. (2008) · Diabetes · doi:10.2337/db08-0063 · Cited by 1,310
The Diabetes Control and Complications Trial Research Group (1995) · Diabetes · doi:10.2337/diab.44.8.968 · Cited by 1,301
Bolinder, J., Antuna, R., Geelhoed-Duijvestijn, P., Kröger, J., & Weitgasser, R. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31535-5 · Cited by 893
Cited by
Items 501–568 of 568
"Usefulness of continuous interstitial glucose in diabetic patient undergoing hemodialysis
Berchoux, E., Szwarc, I., Bonnet, J., Pissarra, J., Avignon, A., Jugant, S., Quintrec, M. L., & Sultan, A. (2025) · Diabetes & Metabolism · doi:10.1016/j.diabet.2025.101720
Liu, Y., Chen, D., He, K., Wei, J., Liang, M., Li, H., Li, J., Li, X., & Wang, X. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1608458
Frizziero, L., Barratt, J., Cheung, C. M. G., Korol, A. R., Midena, E., Talks, J. S., Tsilimbaris, M. K., Pearce, I., & Kozak, I. (2025) · Eye · doi:10.1038/s41433-025-04112-6
Abstracts from ABCD Conference: Newcastle, November 2025
Kong, M. (2025) · British Journal of Diabetes · doi:10.15277/bjd.2025.498
Yang, Y., Zhao, L.-H., Li, D.-D., Xu, F., Wang, X.-H., Lu, C., Wang, C.-H., Yu, C., Zhang, X.-L., Ning, L.-Y., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16674866
He, W., Fang, T., Fu, X., Lao, M., & Xiao, X. (2024) · Figshare · doi:10.6084/m9.figshare.26676803
Dong, S., Wang, L., Zhao, C., Zhang, R., Gao, Z., Jiang, L., Guo, Y., Zhou, H., & Xu, S. (2024) · Figshare · doi:10.6084/m9.figshare.26590634
Al-Harbi, M. Y., Albunyan, A., Alnahari, A., Kao, K., Brandner, L., Jammal, M. E., & Dunn, T. C. (2022) · Figshare · doi:10.6084/m9.figshare.19695806
Bezerra, M. F., Neves, C., Neves, J. S., & Carvalho, D. (2023) · Figshare · doi:10.6084/m9.figshare.24636469
Ćirić, V. (2023) · National Repository of Dissertations in Serbia
SMALDONE, M. (2024) · Electronic Theses and Dissertations Repository (University of Pisa)
Lebbar, M. (2023) · Papyrus : Institutional Repository (Université de Montréal) · doi:10.71781/31580
Alobaid, A. M. (2024) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Farmácia Central Barros, Freamunde
Coelho, J. R. M. (2024) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/6rar-c828
Development of the health economic model for type 2 diabetes considering glycaemic variability
Gu, Z., Chen, L., Zhan, K., Xi, X., & Wang, J. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70451
Wu, Q., Wang, B., Yang, X., Wang, Y., & Cai, W. (2026) · Research Square · doi:10.21203/rs.3.rs-8461092/v1
Continuous Blood Glucose Monitoring: Potential Applications from Diabetes Management
Manaf, F. A., Amin, M. Q. A. M., Ahmad, A., Farizan, N. H., Sukri, N. M., & Maliki, A. B. H. M. (2025) · Malaysian Journal of Medicine and Health Sciences · doi:10.47836/mjmhs.21.4.41
Torimoto, K., Okada, Y., Tomoya, M. I. T. A., Tanaka, K., Sato, F., Katakami, N., Yoshii, H., Nishida, K., Nakayamada, S., Ishii, R., et al. (2026) · Diabetes Technology & Therapeutics · doi:10.1177/15209156251403563
Saba-Abusada, A. (2024) · Universidad Peruana Cayetano Heredia Institutional Repository
Nguyễn, M. T., Lê, M. L., Nguyễn, P. T., & Trương, T. N. (2025) · Tạp chí Y Dược học Cần Thơ · doi:10.58490/ctump.2025i90.3153
Oltre i target glicemici: effetto legacy e variabilità glicemica nelle complicanze del diabete
Barone, S., & Sacchetta, L. (2026) · L Endocrinologo · doi:10.1007/s40619-026-01765-7
Liu, V. B., Sue, L. Y., Byrd, T. F., Padilla, O. M., & Wu, Y. (2026) · Research Square · doi:10.21203/rs.3.rs-9067817/v1
Takuma, K. (2024) · Institutional Repositories DataBase (IRDB)
Alba-Linero, C., Ruiz, J. C., Luque, M. M., Espíldora-Hernández, J., & Gutiérrez‐Bedmar, M. (2026) · Diabetology · doi:10.3390/diabetology7040065
Etude du rôle des monocytes dans la pathogénèse du diabète et de ses complications
Julla, J. (2021) · theses.fr (ABES) · doi:10.70675/b078cadfze5b6z48f4z9223z8a783eac585f
Jin, Z., Dong, Y., Xue, R., Fan, X., & Wan, G. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1803639
曹, 丁. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1641687
Ji, Y. (2026) · cIRcle (University of British Columbia)
Sannigrahi, N., & Chakraborty, A. (2026) · International Journal of Current Pharmaceutical Review and Research · doi:10.25258/ijcpr.18.4.150
Hu, X., Liu, W. T., Fang, Y., Zhu, Y., Zhang, M., Gong, S., Wang, X., Lin, C., Liu, G., Yang, X., et al. (2026) · Health Data Science · doi:10.34133/hds.0298
Predicting complications for diabetes in South Asians: Beyond convention
Lin, B., Lim, L.-L., Mohan, V., & Shaw, J. E. (2026) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2026.102119
李, 晓. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1652017
Samant, P., JOSHI, A. K., Mundra, M., NERKAR, P., & Chakarbarty, S. (2026) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20261687
Yoo, J., Rachim, V. P., Lee, Y., Lee, J., & Park, S.-J. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.25.727637
Association Between Longitudinal Time in Range and Albuminuria in Insulin-Treated Diabetes
Yoshimura, K., Miyazaki, Y., Kobayashi, M., Nakatsuji, M., Saito, S., Nishikage, S., Yamamoto, A., Takayoshi, T., Asahara, S., Ogawa, W., et al. (2026) · Diabetes Technology & Therapeutics · doi:10.1177/15209156261462229
Qian, T., Guo, D., Zhang, M., Liu, Y., & Jin, J. (2026) · Diabetic Medicine · doi:10.1111/dme.70404
Terbosh, M., Dubaj, M., Ignarska, J., Judzińska, A., `Mzabi, S. K., Kwolek, M., Osipowska, J., Piech, B., Sobczyńska, K., & Trojanowska, E. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.2(50).2026.5614
井上, 真. (2026) · Institutional Repositories DataBase (IRDB)
Sun, Y., Li, X., & Xu, L. (2026) · Endocrine · doi:10.1007/s12020-026-04699-0
Qian, T., Fu, M., Zhou, H., Zhang, Z., & Hu, Y. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1867803
Xu, K., Wang, Z. T., Liu, F., Liu, L., Mintian, Z., Wang, Y., Yin, D., & Fang, F. (2026) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2026.112050
Time in Range and Adverse Outcomes in Type 2 Diabetes: A Quantitative Synthesis
Qu, F., Yang, Q., Zeng, Q., Li, Z., & Li, J. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15145713
Su, H., Ni, J., Cai, J., Zhu, W., Wang, Y., Zhou, J., Lu, J., & Ma, X. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.71143
Self-citationNatalia, G. (2026) · Journal of chemical health risks · doi:10.52783/jchr.v16.i4.15879
Abhishek, A., Verma, R., & Guria, R. T. (2026) · International Journal of Medical and Biomedical Studies · doi:10.32553/10.32553/ijmbs.v10i3.3309
Su, Y., Han, G., & Su, Q. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1925994
酒井麻有 (2025) · Institutional Repositories DataBase (IRDB)
Association between low-carbohydrate diets and continuous glucose monitoring-derived time in ranges
Osugi, K. (2023) · Institutional Repositories DataBase (IRDB)
Kaczmarski, M., Kamiński, P., Surdacka, L., Jagiełło, J. K., Jakubas, A., Iwanicka, K. A., Pawelec, K., & Jóźwiak, S. M. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.2(50).2026.5663
Glucose Dispersion Is Associated With Contrast Sensitivity Beyond Average GlycemiaPreprint
Zhang, R. (2026) · medRxiv · doi:10.64898/2026.09.08.26362509
Zhang, Y., You, X., Zhang, Y., & Li, J. (2026) · Healthcare and Rehabilitation · doi:10.1016/j.hcr.2026.100099
Lodha, S. M., Kumar, S., Acharya, S., Dhamelia, P. M., & Garg, S. (2026) · Journal of the American Society of Nephrology · doi:10.64898/2026.09.21.26363573
Sotelo, D. J. V. (2022) · Repositorio Institucional Académico , Sistema de Bibliotecas Universidad Andrés Bello (UNAB) (Universidad Andrés Bello (UNAB))
Yartrak, J., Pipatsatitpong, D., & Piumngam, K. (2023) · Journal of the Medical Technologist Association of Thailand
CORRELATION BETWEEN DIABETES DURATION AND SEVERITY OF DIABETIC RETINOPATHY: A CROSS-SECTIONAL STUDY
Nemivant, S. K. K. (2025) · Cuestiones de Fisioterapia · doi:10.48047/gjrc1k39
Lee, M. J., Seo, B.-J., & Cho, J.-H. (2026) · Life · doi:10.3390/life16101667
Continuous Glucose Monitoring Glucometrics and Their Role in Predicting Diabetes Complications
Schweiger, D. Š., Mozzillo, E., & Battelino, T. (2026) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2026.08.019
Gupta, M., Dey, A. K., Goklani, R., MODI, R., & Saraogi, H. (2026) · International Journal of Diabetes and Technology · doi:10.4103/ijdt.ijdt_31_26
Diabetic Retinopathy in Type 2 Diabetes Mellitus: Prevalence, Severity and Associated Risk Factors
Wadud, S. A., Hossain, I., Asma-ul-Hosna, Hossain, M., Deb, P. K., & Hamid, S. (2026) · The Planet · doi:10.5281/zenodo.23911787
Qin, H.-X., Lv, J., Bian, R.-J., Wu, X., Feng, C.-M., Bai, X.-Y., & Liu, J. (2026) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.126422
Su, H., Ni, J., Cai, J., Guo, J., Wang, Y., Ma, X., Lu, J., Zhou, J., & Jiang, F. (2026) · Journal of Diabetes · doi:10.1111/1753-0407.70298
Self-citationJi, S.-H., Dong, C., Chen, R., Shen, C.-C., Xiao, J., Gu, Y.-J., & Gao, J.-L. (2022) · doi:10.3389/fnut.2022.955101.s003
Liang, B., Koye, D. N., Hachem, M., Zafari, N., Braat, S., & Ekinci, E. I. (2022) · doi:10.3389/fcdhc.2022.849725.s001
Lee, S., Lee, S., Kim, K. M., & Shin, J. H. (2023) · doi:10.3389/fmed.2023.1145470.s001
Breyton, A.-E., Lambert-Porcheron, S., Laville, M., Vinoy, S., & Nazare, J.-A. (2021) · doi:10.3389/fendo.2021.666008.s003
Yang, Y., Tan, J., He, Y., Huang, H., Wang, T., Gong, J., Liu, Y., Zhang, Q., & Xu, X. (2023) · doi:10.3389/fendo.2022.1099302.s001
Metadata
- Authors
- Lu, J., Ma, X., Zhou, J., Zhang, L., Mo, Y., Ying, L., Lu, W., Zhu, W., Bao, Y., Vigersky, R. A., & Jia, W.
- Affiliations
- Shanghai Jiao Tong University (CN)
- Walter Reed National Military Medical Center (US)
- Corresponding author
- Zhou, Jian
- Jia, Weiping
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2018-09-10
- Volume
- 41
- Issue
- 11
- Pages
- 2370-2376
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2891930016
- Cited by
- 517
- References
- 32
- Citations by year
- 2026: 45 · 2025: 55 · 2024: 61 · 2023: 70 · 2022: 87 · 2021: 85 · 2020: 71 · 2019: 40 · 2018: 1
- FWCI
- 39.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81100590)
- Shanghai Municipal Education Commission (20161430)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- time in range, continuous glucose monitoring, diabetic retinopathy, type 2 diabetes, glycemic variability, glycemic control, non-proliferative diabetic retinopathy, vision-threatening diabetic retinopathy, retinopathy severity
- MeSH terms
- Aged, Blood Glucose, Blood Pressure, Diabetes Mellitus, Type 2, Diabetic Retinopathy, Female, Fundus Oculi, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Reference Values, Retrospective Studies, Time Factors, Blood Glucose Self-Monitoring
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.